Cite
HARVARD Citation
Carneiro, B. et al. (2023). Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma. Neuro-oncology advances. 5 (1), p. . [Online].